Market Cap
CN¥120.14 Billion
CNY as of July 1, 2025
US$16.77 Billion
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Roche | $260.54 B | 
|  Novartis | $243.50 B | 
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Novo Nordisk | $309.91 B | 
|  UnitedHealth Group | $279.90 B | 
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
 China
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—General
                            China
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—General
                     China Healthcare
                                China Healthcare
                        
                             China Drug Manufacturers—General
                            China Drug Manufacturers—General
                    
                    Zhangzhou Pientzehuang Pharmaceutical. Ltd has the following listings and related stock indices.
Stock: SSE: 600436
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.